Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Zomedica Stock Quote

Zomedica (NYSEMKT: ZOM)

Price as of April 12, 2024, 4:00 p.m. ET

Zomedica Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
ZOM -39.68% -61.11% -17.19% -84%
S&P +23.57% +76.22% +11.98% +136%

Zomedica Company Info

Zomedica Corp. operates as a veterinary health company, which engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. It offers products for dogs and cats by focusing on the unmet needs of clinical veterinarians. Its TRUFORMA biosensor platform is designed to assist practitioners in the diagnosis of complex conditions. The company was founded by Gerald L. Solensky. on January 7, 2013 and is headquartered in Ann Arbor, MI.

News & Analysis


Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.